Pay in 4 interest-free payments of $5.00 Learn more
Ships within 48 hours Β· Estimated delivery Aug 11 - Aug 16
These early signs indicate that the medication is beginning to have an effect
Wegovy Pediatric (Under 12) Dosing: What Parents and Clinicians Need to Know At a glance FDA-approved age range / 12 years and older only Approved pediatric indication / chronic weight management in adolescents with obesity (BMI at or above 95th percentile) Under-12 status / no FDA approval, no completed clinical trials Key trial / STEP TEENS (N=201) tested semaglutide in ages 12 to 17 STEP TEENS result / 16.1% mean BMI reduction vs
Yes, if your weight loss continues steadily and you've reached your target weight, remaining at 2.5 milligrams long-term is medically sound
It is investigational and not approved for public use
Plus, intermittent treatments can bring relief
Heres what we know so far: Big picture: Research shows that reports of mood-related side effects, including anxiety, make up only about 1% of all side effects linked to semaglutide and similar medications
